Page last updated: 2024-10-31

metoclopramide and Nephrotic Syndrome

metoclopramide has been researched along with Nephrotic Syndrome in 1 studies

Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.

Nephrotic Syndrome: A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Webb, D1
Buss, DC1
Fifield, R1
Bateman, DN1
Routledge, PA1

Other Studies

1 other study available for metoclopramide and Nephrotic Syndrome

ArticleYear
The plasma protein binding of metoclopramide in health and renal disease.
    British journal of clinical pharmacology, 1986, Volume: 21, Issue:3

    Topics: Blood Proteins; Humans; In Vitro Techniques; Kidney Diseases; Kidney Failure, Chronic; Metoclopramid

1986